ELI LILLY & Co is 638.1x more valuable than RAPT Therapeutics, Inc. by market capitalization ($1.072 T vs $1.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RAPT | LLY |
|---|---|---|
| Market cap | $1.68 B | $1.072 T |
| US-listed rank | #2237 | #10 |
| Revenue (latest FY) | $0.00 | $65.18B |
| Net income (latest FY) | -$129.87M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 569 | 989 |
ELI LILLY & Co is 638.1x more valuable than RAPT Therapeutics, Inc. by market capitalization ($1.072 T vs $1.68 B).
In their latest fiscal years, RAPT Therapeutics, Inc. reported $0.00 in revenue while ELI LILLY & Co reported $65.18B.
Full pages: RAPT Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.